Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Clin Appl Thromb Hemost. 2012 Oct 17;20(2):169–178. doi: 10.1177/1076029612461846

Table 2.

Hemorrhagic complications associated with anticoagulation in cirrhosis

Author Study design /
Duration
Patients with Cirrhosis Anticoagulation Hemorrhagic Complications
(number of patients)
Garcia-Fuster
et. al6
Retrospective 1992 – 2007 VTE, n= 17 LMWH, n= 11
VKA with 1 week of LMWH bridging, n= 6
83 % (14/17) : Minor
35% (6/17) : Severe requiring transfusion
Francoz
et. al 50
Retrospective
1996 – 2001
SVT, n= 29 with 19 receiving anticoagulation VKA with ≥ 5 days of LMWH bridging, n= 19

*Band ligation prior to anticoagulation
5% (1/19) : Post-ligation bleeding ulcer that occurred as a complication of prophylactic variceal banding
Senzolo
et. al 49
Prospective Unpublished PVT, n= 38 with 26 selected for anticoagulation on the basis of bleeding risks
(Exclusion: cavernous transformation, suboptimal results from endoscopic variceal banding)
LMWH, n= 26

*Band ligation prior to anticoagulation
4% (1/26)
Amitrano
et. al 48
Prospective
2005 – 2006
PVT, n= 39 with 28 selected for anticoagulation
(Exclusion: cavernous transformation of portal vein, hepatocellar carcinoma, Child-Pugh C disease)
LMWH, n= 28

*Band ligation prior to anticoagulation
7% (2/28) : Hypertensive gastropathy
Bechmann
et. al 44
Prospective Unpublished Immobolization/Thrombophilia/Advanced age/Low protein C/S levels/Malignancy/Stroke/Shock/Previous VTE, n= 75
(Exclusion: Cr clearance < 30 ml/min, history of heparin-induced thrombocytopenia or recent major bleeding event)

PVT/SVT/Veno-occlusive disease/Prosthetic aortic valve/Atrial fibrillation, n= 9
Prophylactic LMWH, n= 75




LMWH, n= 9
7% (5/75) : Variceal bleed, hypertensive gastropathy

22% (2/9) : Variceal bleed, hypertensive gastropathy
Delgado
et. al 47
Prospective 2003 – 2010 PVT, n= 55
(Exclusion: cavernous transformation)
LMWH, n= 26
LMWH (median: 17 days, range: 3–179 days) with transitioning to VKA, n= 21
VKA, n= 8
18% (10/55)

Of these, 9% (5/55) thought to be anticoagulation related :oral, vaginal, surgical wound, lower GI, obscure GI bleed

9% (5/55) thought to be cirrhosis related ? : Variceal bleed
Villa et. al 51 Prospective RCT Unpublished n= 70 with 34 randomized to treatment arm
(Study examining anticoagulation use in the prevention of PVT)
LMWH, n= 34 No hemorrhagic complications Withdrawal of 1 patient due to thrombocytopenia

VTE = Deep vein thrombosis/PE, PVT = Portal vein thrombosis, SVT = Splanchnic vein thrombosis, Cr = Creatinine, GI= Gastrointestinal, RCT= Randomized control trial